Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S-10 in Actinic Keratoses
NCT00786994Phase 2Completed
- Sponsor
- Birken AG
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of birch triterpenes in actinic keratosis (AK), sponsored by Birken AG. Started Oct 2008; status: completed.
02
Drugs
birch triterpenes
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00786994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786994.